STOCK TITAN

Millennium Group and Israel Englander report 3.44M MGNX shares (5.4%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

MacroGenics, Inc. reported a Schedule 13G showing that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander have shared voting and dispositive power over 3,435,504 shares of MacroGenics common stock, equal to 5.4% of the class as shown with a 06/01/2026 time anchor. The filing is a joint filing and includes a Joint Filing Agreement dated June 4, 2026.

Positive

  • None.

Negative

  • None.

Insights

Millennium group reports a 3,435,504-share stake (5.4%) with shared control.

The filing lists 3,435,504 shares and 5.4% under shared voting and dispositive power as of 06/01/2026. The ownership is reported via affiliated entities and a joint filing agreement dated June 4, 2026.

Holder decisions will determine future activity; the filing itself is a static disclosure of ownership and control relationships rather than a transaction. Subsequent public filings would show any changes to this position.

Shared voting/dispositive power indicates control via affiliated entities, not direct sole control.

The cover entries show shared voting power 3,435,504 and shared dispositive power 3,435,504. Footnotes explain holdings are held by entities subject to voting control and investment discretion by Millennium affiliates and Mr. Englander.

The joint filing agreement formalizes the group filing; monitor future schedules for any changes in voting alignment or reported beneficial ownership.

Filed date anchor 06/01/2026 date shown near cover entries
Shares reported 3,435,504 shares shared voting and dispositive power reported
Percent of class 5.4% percent of common stock as reported on cover
CUSIP 556099109 MacroGenics common stock identifier
Joint Filing Agreement dated June 4, 2026 Exhibit I to the Schedule 13G
Schedule 13G regulatory
"MacroGenics, Inc. reported a Schedule 13G showing that Millennium Management LLC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared dispositive power regulatory
"Shared Dispositive Power 3,435,504.00 is shown on the cover entries"
shared voting power regulatory
"Shared Voting Power 3,435,504.00 is shown on the cover entries"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Joint Filing Agreement legal
"Exhibit I: Joint Filing Agreement, dated as of June 4, 2026"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





556099109

(CUSIP Number)
06/01/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/04/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/04/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/04/2026
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 4, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake does Millennium report in MacroGenics (MGNX)?

The filing reports 3,435,504 shares of MacroGenics common stock, representing 5.4% of the class as shown with a 06/01/2026 anchor. The position is reported jointly by Millennium entities and Israel A. Englander.

Who has voting and dispositive power over the reported shares?

Shared voting power and shared dispositive power of 3,435,504 shares are reported for Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander in the Schedule 13G.

Does the Schedule 13G indicate a change in ownership or a transaction?

The Schedule 13G discloses beneficial ownership and control relationships; it does not itself report a purchase or sale transaction. The filing lists holdings and a Joint Filing Agreement dated June 4, 2026.

What is the CUSIP and class of the securities reported?

The filing lists the security as Common Stock, par value $0.01 with CUSIP 556099109. The reported holdings relate to MacroGenics common shares.